Internal Medicine, Hematology & Oncology · Lexington, KY
NPI
1154434645
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
UK Medical Oncology, 800 Rose Street, Cc401 Roach Building
Lexington, KY, 40536
Phone (859) 323-6522
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
248 services
Medicare patients, 2024
122
Average age 67
Drug cost, 2024
$2.0M
672 prescriptions
Company payments, 2025
$3,785
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John L Villano was code 99214 (office e&m - established), 93 times for 43 patients. In total John L Villano billed 248 services in 12 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 93 | 43 | $70.40 | $6,547 |
| 99215 Office E&M - Established | Facility | 58 | 24 | $110.29 | $6,397 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $105.34 | $2,528 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 19 | $95.60 | $2,199 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $129.83 | $2,337 |
| 99204 Office E&M - New | Facility | 11 | 11 | $107.16 | $1,179 |
By year: 2022 $28K for 314 services; 2023 $23K for 280 services; 2024 $23K for 248 services.
Medicare prescription drug claims, 2024
In 2024, the drug John L Villano prescribed most often to Medicare patients was Prochlorperazine Maleate, with 72 prescriptions and refills. In total John L Villano wrote 672 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 72 | 72 | 43 | $1,105 |
| Dexamethasone Generic | 63 | 72 | 27 | $885 |
| Ondansetron Hcl Generic | 63 | 65 | 34 | $13K |
| Levetiracetam Generic | 55 | 67 | 20 | $918 |
| Methylphenidate Hcl Generic | 23 | 23 | 11 | $456 |
| Oxycodone Hcl Generic | 22 | 22 | Under 11 | $396 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 22 | 16 | $47.35 |
| Mirtazapine Generic | 17 | 21 | Under 11 | $307 |
| Tibsovo Ivosidenib | 16 | 16 | Under 11 | $477K |
| Voranigo Vorasidenib Citrate | 15 | 15 | Under 11 | $555K |
| Promethazine Hcl Generic | 14 | 14 | Under 11 | $17.59 |
| Koselugo Selumetinib Sulfate | 14 | 14 | Under 11 | $304K |
| Tagrisso Osimertinib Mesylate | 13 | 13 | Under 11 | $219K |
| Imatinib Mesylate Generic | 13 | 13 | Under 11 | $1,376 |
| Aprepitant Generic | 13 | 13 | Under 11 | $5,714 |
Brand drugs: 120 claims; generic drugs: 552 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John L Villano $3,785 ($3,785 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,015.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.